US Patent 9862760 Polyomavirus neutralizing antibodies
Patent 9862760 was granted and assigned to Novartis on January, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+188 characters)
Article
Patent abstract
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Adam Lloyd Feire0
Danqing Wu0
Elisabetta Traggiai0
Fangmin Xu0
Johanna Abend0
Lichun Wang0
Mark Knapp0
Qilong Wu0
Steven Kovacs0
Yongqiang Wang0
Zorica Dragic0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09862760 Polyomavirus neutralizing antibodies US Patent 9862760 Polyomavirus neutralizing antibodies
Infobox
Patent Number
098627600
Patent Number
98627600
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
098627600
Date of Patent
January 9, 2018
0Patent Application Number
152589250
Date Filed
September 7, 2016
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09862760 Polyomavirus neutralizing antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09862760
Date of patent
January 9, 2018
Patent application number
15258925
Date Filed
September 7, 2016
Patent primary examiner
Find more entities like US Patent 9862760 Polyomavirus neutralizing antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
